{"doi":"10.4174/jkss.2009.77.1.37","title":"Clinicopathologic Characteristics and Prognosis of Early Stage Triple Negative Breast Cancer: Comparison with Non-triple Negative Group","abstract":null,"journal":"Journal of the Korean Surgical Society","year":2009,"id":625808,"datarank":0.20794415416798362,"base_score":1.3862943611198906,"endowment":1.3862943611198906,"self_citation_contribution":0.20794415416798362,"citation_network_contribution":0.0,"self_endowment_contribution":0.20794415416798362,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":3,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":1618614,"name":"Jihyoung Cho","orcid":null,"position":1,"is_corresponding":false},{"id":1247387,"name":"Sun Young Kwon","orcid":"0000-0002-8410-0185","position":2,"is_corresponding":false},{"id":1618615,"name":"Sun Hee Kang","orcid":null,"position":3,"is_corresponding":false},{"id":1618613,"name":"Jae Seok Ahn","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Clinicopathologic Characteristics and Prognosis of Early Stage Triple Negative Breast Cancer: Comparison with Non-triple Negative Group","abstract":"Purpose: Triple negative breast cancer (estrogen receptor-negative, progesterone receptor negative, and HER2/neu negative) is associated with high risk of recurrence and poor prognosis. We investigated the characteristics and prognosis of triple negative early-stage breast cancer.\\nMethods: We reviewed the records of 821 early-stage breast cancer patients treated at our hospital from 1995 to 2005. We studied the differences between a triple negative group compared with a non-triple negative group.\\nResults: Of 821 early-stage breast cancer patients, 200 (24.4%) were classified as triple negative. Large tumors (＞2 cm) in the triple negative group were significantly more than those in the non-triple negative group (P=0.042). Histologic and nuclear grade of the triple negative group were significantly higher than those of the non-triple negative group (P＜0.001). The median follow-up time is 50 months (1∼135). There have been 50 local recurrences, 98 distant metastases, and 65 deaths. There were high rates of local recurrence in the triple negative group but no difference in 5-year disease free survival rates (P=0.178). The 5-year overall survival rate showed 85% in the triple negative group but 92.8% in the non-triple negative group (P=0.008). The relative risk for overall survival was 1.93 times higher in the triple negative group.\\nConclusion: Triple negative breast cancer patients in early stages have poor pathologic findings and prognoses. Careful treatment and follow-up are important and further investigation is necessary for triple negative breast cancer.","is_dataset_classified":null,"base_score":1.3862943611198906,"endowment":1.3862943611198906,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"19767382","pmcid":null,"openalex_id":"https://openalex.org/W1535396021","authors":[],"funders":[],"total_grants":0,"fwci":0.1055,"citation_percentile":0.55374553,"influential_citations":0,"citation_trend":[{"year":2012,"count":1},{"year":2021,"count":1},{"year":2023,"count":1}],"oa_status":"gold","license":"cc-by-nc-nd","oa_locations":[{"url":"https://doi.org/10.4174/jkss.2009.77.1.37","host_type":"journal"},{"url":"https://doi.org/10.4174/jkss.2009.77.1.37","host_type":"publisher"},{"url":"https://synapse.koreamed.org/DOIx.php?id=10.4174/jkss.2009.77.1.37","host_type":"publisher"},{"url":"https://synapse.koreamed.org/pdf/10.4174/jkss.2009.77.1.37","host_type":"publisher"},{"url":"https://astr.or.kr/Synapse/Data/PDFData/0037JKSS/jkss-77-37.pdf","host_type":"publisher"},{"url":"http://kumel.medlib.dsmc.or.kr/handle/2015.oak/38231","host_type":"repository"}],"fields_of_study":["Breast Cancer Treatment Studies","HER2/EGFR in Cancer Research","Advanced Breast Cancer Therapies"],"mesh_terms":[],"keywords":["Triple-negative breast cancer","Medicine","Breast cancer","Triple negative","Internal medicine","Stage (stratigraphy)","Oncology","Cancer","Triple test","Gastroenterology"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-04T10:48:58.192738Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}